251 related articles for article (PubMed ID: 21887500)
1. A phase IIa randomized controlled pilot study evaluating the safety and clinical outcomes following the use of rhGDF-5/β-TCP in regenerative periodontal therapy.
Windisch P; Stavropoulos A; Molnár B; Szendröi-Kiss D; Szilágyi E; Rosta P; Horváth A; Capsius B; Wikesjö UM; Sculean A
Clin Oral Investig; 2012 Aug; 16(4):1181-9. PubMed ID: 21887500
[TBL] [Abstract][Full Text] [Related]
2. A phase IIa randomized controlled clinical and histological pilot study evaluating rhGDF-5/β-TCP for periodontal regeneration.
Stavropoulos A; Windisch P; Gera I; Capsius B; Sculean A; Wikesjö UM
J Clin Periodontol; 2011 Nov; 38(11):1044-54. PubMed ID: 22092476
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
[TBL] [Abstract][Full Text] [Related]
4. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
[TBL] [Abstract][Full Text] [Related]
6. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled clinical study of rhPDGF-BB + β-TCP versus HA + β-TCP for the treatment of infrabony periodontal defects: clinical and radiographic results.
Thakare K; Deo V
Int J Periodontics Restorative Dent; 2012 Dec; 32(6):689-96. PubMed ID: 23057058
[TBL] [Abstract][Full Text] [Related]
8. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of β-tricalcium phosphate in human infrabony periodontal osseous defects: a clinical study.
Chawla K; Lamba AK; Faraz F; Tandon S
Quintessence Int; 2011 Apr; 42(4):291-300. PubMed ID: 21516274
[TBL] [Abstract][Full Text] [Related]
10. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.
Gamal AY; Mailhot JM
J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyapatite/β-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial.
Peres MF; Ribeiro ED; Casarin RC; Ruiz KG; Junior FH; Sallum EA; Casati MZ
J Clin Periodontol; 2013 Mar; 40(3):252-9. PubMed ID: 23379539
[TBL] [Abstract][Full Text] [Related]
12. Comparison between a β-tricalcium phosphate and an absorbable collagen sponge carrier technology for rhGDF-5-stimulated periodontal wound healing/regeneration.
Kim YT; Wikesjö UM; Jung UW; Lee JS; Kim TG; Kim CK
J Periodontol; 2013 Jun; 84(6):812-20. PubMed ID: 22897651
[TBL] [Abstract][Full Text] [Related]
13. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
[TBL] [Abstract][Full Text] [Related]
14. Gingival crevicular fluid vascular endothelial cell growth factor and platelet-derived growth factor-BB release profile following the use of perforated barrier membranes during treatment of intrabony defects: a randomized clinical trial.
Gamal AY; Abdel-Ghaffar KA; Iacono VJ
J Periodontal Res; 2016 Jun; 51(3):407-16. PubMed ID: 26549803
[TBL] [Abstract][Full Text] [Related]
15. Growth/differentiation factor-5 significantly enhances periodontal wound healing/regeneration compared with platelet-derived growth factor-BB in dogs.
Kwon HR; Wikesjö UM; Park JC; Kim YT; Bastone P; Pippig SD; Kim CK
J Clin Periodontol; 2010 Aug; 37(8):739-46. PubMed ID: 20618546
[TBL] [Abstract][Full Text] [Related]
16. Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 in a beta-tricalcium phosphate carrier into one-wall intrabony defects in dogs.
Lee JS; Wikesjö UM; Jung UW; Choi SH; Pippig S; Siedler M; Kim CK
J Clin Periodontol; 2010 Apr; 37(4):382-9. PubMed ID: 20447262
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline-loaded β-tricalcium phosphate release following EDTA root surface etching improved the clinical outcomes in chronic periodontitis: an in vivo study.
Gamal AY; Kumper RM; Al Gendy Ael R
J Periodontol; 2013 Jul; 84(7):924-33. PubMed ID: 23003915
[TBL] [Abstract][Full Text] [Related]
18. Volumetric analysis of intrabony defects in aggressive periodontitis patients following use of a novel composite alloplast: a pilot study.
Kumar PG; Kumar JA; Anumala N; Reddy KP; Avula H; Hussain SN
Quintessence Int; 2011 May; 42(5):375-84. PubMed ID: 21519556
[TBL] [Abstract][Full Text] [Related]
19. Clinical and radiographic evaluation of regenerative potential of GTR membrane (Biomesh®) along with alloplastic bone graft (Biograft®) in the treatment of periodontal intrabony defects.
Mopur JM; Devi TR; Ali SM; Srinivasa TS; Gopinath V; Salam AR
J Contemp Dent Pract; 2013 May; 14(3):434-9. PubMed ID: 24171985
[TBL] [Abstract][Full Text] [Related]
20. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
